N
NRx Pharmaceuticals, Inc. (NRXP)
NCM – Real vaqt narxi. Valyuta: USD
3.73
+0.17 (4.78%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.08 (2.14%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.73
+0.17 (4.78%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.08 (2.14%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $6.7M umumiy qarzdan $934.0K sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy majburiyatlar $25.2M jami joriy aktivlardan $7.4M oshib ketdi, likvidlik muammolarini ko'rsatadi
Qarz/kapital nisbati (-0.1) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-20.4x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$4.3M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.29 | 6.05 | 3.0 | |
| Tezkor likvidlik nisbati | 0.29 | 5.63 | 3.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.08 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | -20.38 | -16.91 | 1.0 | |
| O‘rtacha ball | 3.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | 1M | 2M |
| Yalpi foyda | -4K | -5K | -5K | 577K | 851K |
| Operatsion daromad | -44M | -28M | -20M | -16M | -17M |
| Sof foyda | -40M | -30M | -25M | -29M | -25M |
| EBITDA | -44M | -28M | -20M | -16M | -17M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 88.48 | 5.5 |
| Keyingi chorak | 999.69 | 60.72 | 10 |
| Joriy yil | 1034.18 | 72.07 | 10 |
| Keyingi yil | 1091.94 | 194.21 | 10 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 8.65 | -497.21 | -499.99 | -15.66 | 2.3 |
| Yil/Yil | 999 | 74.06 | 88.24 | -23.41 | 7.8 |
| 3 yil o‘rtacha | 999 | 8.97 | 39.55 | 21.25 | 9.0 |
| 5 yil o‘rtacha | 999 | 0.89 | 39.55 | -300.95 | 5.8 |
| O‘rtacha ball | 6.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |